US 9526796
Peptide-based in vivo siRNA delivery system
granted A61KA61K47/549A61K47/64
Quick answer
US patent 9526796 (Peptide-based in vivo siRNA delivery system) held by Arrowhead Pharmaceuticals, Inc. expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/549, A61K47/64, A61K47/6415, A61P